header

ReSHAPE PUBLICATIONS

  • Léa Flippe, Séverine Bézie, Ignacio Anegon,vCarole Guillonneau.
    Future prospects for CD8+ regulatory T cells in immune tolerance.
    Immunological reviews, 2019, 292, 1-16, DOI: 10.1111/imr.12812
    → open it on the web
  • Séverine Ménoret, Laure-Hélène Ouisse, Laurent Tesson, Séverine Remy, Claire Usal, Aude Guiffes, Vanessa Chenouard, Pierre-Joseph Royer, Gwenaelle Evanno, Bernard Vanhove, Eliane Piaggio, and Ignacio Anegon.
    In vivo analysis of human immune responses in immunodeficient rats.
    Transplantation, 2020, 104/4, 715-723, DOI: 10.1097/tp.0000000000003047
    → open it on the web
  • George Adigbli, Séverine Ménoret, Amy R Cross, Joanna Hester, Fadi Issa, Ignacio Anegon.
    Humanization of immunodeficient animals for the modelling of transplantation, graft-versus host disease and regenerative medicine.
    Transplantation, ahead of print , DOI: 10.1097/tp.0000000000003177
    → open it on the web
  • Enrico Fritsche, Hans-Dieter, Volk Petra Reinke, Mohamed Abou-El-Enein.
    Toward an optimized process for clinical manufacturing of chimeric antigen receptor regulatory T-cell therapy (CAR-Treg) Trends in Biotechnology.
    Trends in Biotechnology, 2020, 1-13 , DOI: 10.1016/j.tibtech.2019.12.009
    → open it on the web
  • Enrico Fritsche, Magdi Elsallab, Michaela Schaden,Spencer Phillips Hey, Mohamed Abou-El-Enein.
    Post-marketing safety and efficacy surveillance of cell and gene therapies in the EU: A critical review.
    Cell & Gene Therapy Insights, 2019; 5(11), 1505–1521, DOI: 10.18609/cgti.2019.156
    → open it on the web
  • Matthew Brook, Joanna Hester, Fadi Issa.
    New frontiers: cellular immunotherapy beyond cancer.
    Cell and Gene Therapy Insights,2019, 1229-1236, DOI: 10.18609/cgti.2019.163
    → open it on the web

ReSHAPE CONFERENCES

Type Researcher(s) involved Event (Title, location, dates) Activity title
(e.g. title of poster or talk, etc.)
Type of audience Estimated persons reached
Participation to a conference P1-CHARITE: L. Amini, Schmueck-Henneresse 1ST IMMUNOLOGY & INFLAMMATION CONFERENCE, 24. - 26.02. 2019 Immunosuppressant-resistant T cells for advanced adoptive T cell therapy in immunosuppressed patients Scientific Community (Higher Education, Research) >1000
Participation to an event other than a conference or workshop P1- CHARITE: P. Reinke British German Alliance for Advanced Therapies, British Embassy, Berlin (Germany), 26.03.2019 ReSHAPE by next generation Treg approaches - An EU Consortium coordinated by BeCAT Policy Makers 53
Participation in activities organised jointly with other H2020 project(s) P1- CHARITE: H.-D. Volk; P. Reinke Kick-off meeting of the RESTORE community, Berlin (Germany), 06.-07.05.2019 Promoting Advanced therapies and strenghten the development of Advanced Therapies in the European market Other >320
Participation to a conference P1- CHARITE: L. Amini, Schmueck-Henneresse Allogenic Cell Therapies Summit, 7.-9.05.2019 Antiviral and CAR-T cell products for advanced adoptive T cell therapy Scientific Community (Higher Education, Research) >100
Participation to a conference P1- CHARITE: P. Reinke; J. Wendering; L.Amini FOCIS Annual Meeting 2019, Boston (US), 18.-21.06.2019 Next-Generation Regulatory T Cell Therapy; The Value of a Rapid Test of Huamn Regulatory T Cell Function Needs to be Revised (poster) Scientific Community (Higher Education, Research) >1060
Participation to a conference P1- CHARITE: L. Amini Cell & Gene Therapy Bioprocessing & Commercialization, 9.-12.09.2019   Investors >2000
Participation to a conference P1- CHARITE: P. Reinke Phacilitate Leader Europe 2019, London (UK), 17.-18.09.2019 RESTORE/RESHAPE faces challenges in manufacturing of Advanced Therapies Scientific Community (Higher Education, Research) >350
Participation to a conference P1- CHARITE: P. Reinke; L.Amini 7th Annual Conference of the German Stem Cell Network, Berlin (Germany), 23.-25.09.2019 Next-generation regulatory T cell products - opportunities and challenges Scientific Community (Higher Education, Research) >400
Participation to an event other than a conference or workshop P1- CHARITE: P. Reinke Promoting Translational Research in University Medicine, Berlin (Germang), 08.12.2019 Early clinical trials with ATMPs Scientific Community (Higher Education, Research) >100
Participation to an event other than a conference or workshop P1- CHARITE: P. Reinke; N. M. Otto, Schmueck-Henneresse RegMed Forum 2019: cell and gene therapies, Berlin (Germany), 22.10.2019 Regulatory T cells: A treatment option for balancing immune responses; Regulatory T cell therapy in solid organ transplantation; Other >120
Participation in activities organised jointly with other H2020 project(s) P1- CHARITE: H.-D. Volk; P. Reinke; L. Amini, Schmueck-Henneresse RESTORE: 1st Advanced Therapy Science Meeting, Berlin (Germany), 25.-26.11.2019 RESTORE - Health by Advanced Therapies - Opportunities and Challenges; Reshape immune balance by next-generation regulatory T cells; Other 400
Participation to a conference P1- CHARITE: Julia Polansky-Biskup RESTORE: 1st Advanced Therapy Science Meeting, Berlin (Germany), 25.-26.11.2019 invited talk: Epigenetic control of T cell differentiation: From genome-wide signatures to local regulators and their targeted manipulation. Scientific Community (Higher Education, Research) 400
Participation to a conference P1- CHARITE: L. Amini, Schmueck-Henneresse The Hitchhiker’s Guide to Regenerative Therapies, 03.-06.12.2019 Immunosuppressant-resistant antiviral and regulatory T cell products for advanced adoptive T cell therapy in immunosuppressed patients Scientific Community (Higher Education, Research) >100
Participation to a conference P4-UOXF: Fadi Issa "Nanostring EU Summits: Crosstalk" 23 Oct 2019, Birmingham, UK "How nanoString can enrich transplant studies" - talk Scientific Community (Higher Education, Research) 100
Participation to a conference P4-UOXF: Fadi Issa International Transplantation Science Meeting, 10 - 13th November 2019, Clearwater Beach, Florida, USA   Scientific Community (Higher Education, Research) 200
Participation to an event other than a conference or workshop P4-UOXF: Joanna Hester RESTORE: 1st Advanced Therapy Science Meeting, Berlin (Germany), 25.-26.11.2019 "The TWO Study – A Phase II Trial of Regulatory T Cell Therapy in Renal Transplantation" - poster Scientific Community (Higher Education, Research) 400
Participation to a conference P4-UOXF: Fadi Issa The 4th International Workshop on Clinical Tolerance Update on the Oxford/London ONE and TWO Studies Scientific Community (Higher Education, Research) 100
Participation to an event other than a conference or workshop P5-Markus Templin Virologisch-wissenschaftliches Kolloquium University Clinic Tübingen Germany Talk: Multiplexed Immunoassays - Characterisation of Immune Cells Scientific Community (Higher Education, Research) 60
Participation to an event other than a conference or workshop P6- CTC: Ilaria Santeramo CGTC's regular lab meeting, CGTC, 21 August 2019 Internal talk Scientific Community (Higher Education, Research) 50
Participation to a conference P10-Ignacio Anegon FOCISed in South East Asia 1st Annual Course: Advances in Immunology, Immune Monitoring, and Immunotherapy. Jaipur, India. March 26-29, 2019. talk Scientific Community (Higher Education, Research) 120
Participation to a conference P10- UN Ignacio Anegon Latin American Society for Immunology and French Society for Immunology joint meeting. FOCIS annual meeting. Cancun, Mexico. June 18th 2019. I. Anegon. CD8+ Tregs in transplantation. talk Scientific Community (Higher Education, Research) 100
Participation to a conference P10- UN Carole Guillonneau 3) Day of Immunotechnologies, Institut Gustave Roussy, Paris, France. 26th Septembre 2019. C. Guillonneau, Anti-CD45RC to eliminate Teffs and induce Tregs in transplantation and autoimmune diseases talk Scientific Community (Higher Education, Research) 150
Participation to a conference P10- UN Carole Guillonneau ThymE: T cell and thymus biology, Rehovot, Israel 19-23 May 2019. C. Guillonneau, Anti-CD45RC to eliminate Teffs and induce Tregs in APECED disease. talk    
Participation to a conference P10- UN What’s up in Immunotherapy, 31st January 2019, C. Guillonneau, Nantes, France. Anti-CD45RC to eliminate Teffs and induce Tregs in transplantation and autoimmune diseases. talk    
Participation to a conference P10- UN Séverine Bézie ThymE: T cell and thymus biology. Rehovot, Israel, 19-23 May 2019. S. Bézie (poster) Human CD8+ Treg mediated inhibition of GVHD and human skin rejection in NSG mice.      
Participation to a conference P10- UN Carole Guillonneau Annual Meeting of the French Society for Immunology, Nantes, France. 12-14rd November 2019 oral presentation, title: Anti-CD45RC to eliminate Teffs and induce Tregs in transplantation and autoimmune diseases.    
Participation to a conference P10- UN Séverine Bézie Annual Meeting of the French Society for Immunology, Nantes, France. 12-14th November 2019 Oral presentation, title: Human CD8+ Treg suppress human skin rejection and GVHD in NSG mice.    

ReSHAPE PRESS RELEASES


Press releases and other dissemination material will be available soon.